Add To Watchlist
Share URL
Jazz Pharmaceuticals plc
JAZZ: NasdaqGSLowest reading is at 34 out of 100. All scores are out of 100.
In Short
About The Company
CEO
Ms. Renee D. Gala
Market Cap
13.65 Billion USD
Sector
Healthcare
Website
https://www.jazzpharma.comLast Update
15/10/2026, 01:08:22
Description
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
Read More
Strongest readings
No reading stands out above its benchmark.
Weakest readings
- ✘Price-to-earnings of 1213.4 is above the market average of 19.6
- ✘Earnings have fallen this year (-95.94%)
- ✘Revenue is growing at 6.12% per year while free cashflow is falling
- ✘Earnings are negative at -5.84 per share
- ✘The current price sits above estimated fair value (margin of safety -62.25%)
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings (TTM) | 1213.44x | 19.60x | |
| ✘ | Margin of safety (DCF) | -62.25% | 17.95% | |
| ✘ | Revenue growth (5y average) | 6.12% | 10.97% | |
| ✘ | Dividend yield (TTM) | 0.00% | 1.85% | |
| ✘ | Share count, per year | 1.82% | 0.00% | |
| ✘ | Return on capital employed | -4.60% | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
60 / 100Priced at or below the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings | 1213.44x | 19.60x | |
| ✔ | Free cashflow yield | 9.32% | 4.70% | |
| Price / earnings growth | N/A | 1.50x | ||
| Price / book | 2.95x | — | ||
| ✘ | Margin of safety | -62.25% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 82.45 USD is below the current price of 210.23 USD
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: 243.6 USD ✔
Current Price: 218.4 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
48 / 100Growing more slowly than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Revenue growth | 6.12% | 10.97% | |
| ✔ | Earnings growth | 38.32% | 14.48% | |
| ✘ | Cashflow growth | -4.48% | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✔Revenue growth has improved this year (14.71% against a five year average of 6.12%)
- ✘Earnings growth has slowed this year (-95.94% against a five year average of 38.32%)
- ✘Free cashflow growth has slowed this year
- ✘Revenue is growing at 6.12% per year while free cashflow is falling at 4.48% per year
Health
40 / 100Balance sheet is stretched on several measures.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✘ | Altman-Z score | 1.68 | 3.00 | |
| ✔ | Piotroski score | 5.00 | 5.00 | |
| ✘ | Debt / equity | 1.24x | 0.80x | |
| ✔ | Current ratio | 1.86x | 1.00x | |
| ✘ | Interest coverage | -2.22x | 2.50x | |
| ✔ | Free cashflow / debt | 0.24x | 0.15x | |
| ✔ | Debt / capital | 0.55x | 1.00x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Management
34 / 100Returns on capital are below the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Return on equity | -8.25% | 15.00% | |
| ✘ | Return on capital employed | -4.60% | 10.00% | |
| Return on assets | -3.05% | — | ||
| Free cashflow return on capital | 13.77% | — | ||
| ✘ | Return on capital, 5y change | -3.02% | 0.00% | |
| ✘ | Share count, per year | 1.82% | 0.00% | |
| ✘ | Share count, recent | 6.45% | 0.00% | |
| ✘ | Realized buyback return | -40.84% | 0.00% | |
| ✘ | Goodwill erosion / equity | 3.98% | 2.00% | |
| Price volatility, 5 year | 31.31% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘New shares were issued while the value score was 60 out of 100
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
JAZZ
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
Jazz Pharmaceuticals plc
Currency
USD
Beta
0.36
Vol Avg
863642
Ceo
Ms. Renee D. Gala
Cik
0001232524
Cusip
Exchange
NasdaqGS
Full Time Employees
2890
Industry
Biotechnology
Sector
Healthcare
Ipo Date
Address
Waterloo Exchange
City
Dublin
State
Country
Ireland
Zip
D04 E5W7
Phone
353 1 634 7800
Analysis Last Updated
15/10/2026, 01:08:22
Financial data compiled from SEC EDGAR filings and Yahoo Finance.